Fermenta Biotech has informed that the board of directors of the company at its meeting held on May 6, 2021 has approved the following, appointment of Krishna Datla (DIN: 00003247) as a Whole-time Director of the Company (Key Managerial Personnel), designated as Executive Vice-Chairman, for a period of 3 years commencing from May 9, 2021 to May 8, 2024, subject to members' approval at their ensuing general meeting; appointment Prashant Nagre (DIN: 09165447) as an additional director on the Board of Directors of the Company with effective from May 6, 2021; and appointment of Prashant Nagre as (DIN: 09165447) as the Managing Director of the Company (Key Managerial Personnel) for a period of 3 years commencing from May 9, 2021 to May 8, 2024, subject to members' approval at their ensuing general meeting. Requisite details of directors in terms of SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and affirmation pursuant to BSE Circular LIST/COMP/14/2018-19 dated June 20, 2018 are provided in Annexure 1. A copy of the Press Release for the same is attached.
The above information is a part of company’s filings submitted to BSE.
